These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15090554)

  • 1. Optimising the methods of evaluation of the effectiveness of botulinum toxin treatment of post-stroke muscle spasticity.
    Bakheit AM
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):665-6. PubMed ID: 15090554
    [No Abstract]   [Full Text] [Related]  

  • 2. Stroke, spasticity, and botulinum toxin.
    Rowland LP
    N Engl J Med; 2002 Aug; 347(6):382-3. PubMed ID: 12167679
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.
    Cardoso E; Rodrigues B; Lucena R; Oliveira IR; Pedreira G; Melo A
    Arq Neuropsiquiatr; 2005 Mar; 63(1):30-3. PubMed ID: 15830061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin and spasticity.
    Davis EC; Barnes MP
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):143-7. PubMed ID: 10896682
    [No Abstract]   [Full Text] [Related]  

  • 5. [Using botulinum toxin (Botox) for treatment of patients with postroke spasticity].
    Khat'kova SE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):87-90. PubMed ID: 19685598
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of botulinum toxin type A on gait and quality of life in adult post-stroke patients with lower limb spasticity: a systematic review protocol.
    Chu WH; Gupta AD
    JBI Database System Rev Implement Rep; 2016 Jun; 14(6):23-9. PubMed ID: 27532646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of botulotoxin type A(dysport)in the complex therapy of patients with post-stroke spasticity].
    Khat'kova SE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):57-9. PubMed ID: 19255982
    [No Abstract]   [Full Text] [Related]  

  • 8. High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?
    Santamato A; Ranieri M; Solfrizzi V; Lozupone M; Vecchio M; Daniele A; Greco A; Seripa D; Logroscino G; Panza F
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):843-6. PubMed ID: 27291256
    [No Abstract]   [Full Text] [Related]  

  • 9. Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians).
    Bensmail D; Hanschmann A; Wissel J
    J Med Econ; 2014 Sep; 17(9):618-25. PubMed ID: 24841450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A for upper limb spasticity after stroke.
    Shaw L; Rodgers H
    Expert Rev Neurother; 2009 Dec; 9(12):1713-25. PubMed ID: 19951131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The features of botulinum therapy for different patterns of poststroke spasticity].
    Krylova LV; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):42-48. PubMed ID: 28374692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A in children. New indication for limb spasticity.
    Prescrire Int; 2011 Mar; 20(114):68. PubMed ID: 21648226
    [No Abstract]   [Full Text] [Related]  

  • 14. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spasticity Treatment Beyond Botulinum Toxins.
    Li S; Winston P; Mas MF
    Phys Med Rehabil Clin N Am; 2024 May; 35(2):399-418. PubMed ID: 38514226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
    N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study.
    Datta Gupta A; Visvanathan R; Cameron I; Koblar SA; Howell S; Wilson D
    BMC Neurol; 2019 May; 19(1):96. PubMed ID: 31078139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A for refractory post-stroke shoulder pain.
    Pedreira G; Cardoso E; Melo A
    Arq Neuropsiquiatr; 2008 Jun; 66(2A):213-5. PubMed ID: 18545785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
    J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity.
    Rosales RL; Chua-Yap AS
    J Neural Transm (Vienna); 2008; 115(4):617-23. PubMed ID: 18322637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.